AngioDynamics Inc (STU:UG2)
€ 5.9 0.05 (0.85%) Market Cap: 229.90 Mil Enterprise Value: 181.36 Mil PE Ratio: 0 PB Ratio: 1.16 GF Score: 57/100

AngioDynamics Inc at JPMorgan Healthcare Conference Transcript

Jan 16, 2020 / 04:00PM GMT
Release Date Price: €13.3 (-0.75%)
Lilia;Celine Breton Lozada
JP Morgan Chase & Co, Research Division - Research Analyst

Hi, everyone. Thanks for joining us today. My name is Lili Lozada. I'm part of the med tech equity research team here at JPMorgan. After the presentation, the breakout will be in the Kent Room.

And without further ado, it's my pleasure to introduce CEO of AngioDynamics, Jim Clemmer.

James C. Clemmer
AngioDynamics, Inc. - CEO, President & Director

Thank you. Good morning. Thank you for JPMorgan for a great conference and inviting us to join.

So let me remind you, this morning, during our presentation, we're going to give you some forward-looking statements. These are plans and ideas we have about our company and our marketplace. But as savvy investors know, we can't make any guarantees to what we're talking about today, so make sure you read carefully and understand what we're talking about.

So thanks for joining us. Let's share with you our evolution at AngioDynamics. And we are a company in transformation. And a lot of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot